Master of Public Health (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/master-of-public-health
Students of the Master of Public Health acquire profound knowledge in public health and analytical and problem solving competences to address public health related questions. The programme caters to p
Monitoring of Baby Friendly Hospitals in Switzerland (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/monitoring-of-baby-friendly-hospitals-in-switzerland
Since the launch of the Baby Friendly Hospitals Initiative (BHFI) of WHO and UNICEF in 1991, the Baby Friendly Hospitals (BHF) help towards a goof start in life worldwide. In Switzerland, BFH accredit
Evaluation of SARS-CoV-2 total antibody detection via a lateral flow nanoparticle fluorescence immunoassay (Publications)
BACKGROUND: The coronavirus disease 2019 (COVID-19) endgame may benefit from simple, accurate antibody testing to characterize seroprevalence and immunization coverage. OBJECTIVES: To evaluate the per
Efficient identification of high-titer anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody plasma samples by pooling method (Publications)
CONTEXT.-: The ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has elicited a surge in demand for serologic testing to identify previously infected
Use of outpatient-derived COVID-19 convalescent plasma in COVID-19 patients before seroconversion (Publications)
BACKGROUND: Transfusion of COVID-19 convalescent plasma (CCP) containing high titers of anti-SARS-CoV-2 antibodies serves as therapy for COVID-19 patients. Transfusions early during disease course was
SARS-CoV-2 nucleocapsid plasma antigen for diagnosis and monitoring of COVID-19 (Publications)
BACKGROUND: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antigen in blood has been described, but the diagnostic and prognostic role of antigenemia is not wel
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia (Publications)
Different SARS-CoV-2 vaccines are approved in various countries, but few direct comparisons of the antibody responses they stimulate have been reported. We collected plasma specimens in July 2021 from
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine... (Publications)
Although antivirals are important tools to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, effective vaccines are essential to control the current coronavirus disease 2